Rice Hall James & Associates’s Atrion Corp ATRI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-1,917
Closed -$898K 307
2017
Q1
$898K Buy
1,917
+52
+3% +$24.7K 0.04% 252
2016
Q4
$946K Buy
1,865
+322
+21% +$150K 0.05% 247
2016
Q3
$658K Buy
1,543
+18
+1% +$8.01K 0.03% 249
2016
Q2
$652K Sell
1,525
-11
-0.7% -$4.47K 0.04% 249
2016
Q1
$607K Sell
1,536
-204
-12% -$77.1K 0.04% 246
2015
Q4
$663K Buy
1,740
+48
+3% +$18.3K 0.04% 249
2015
Q3
$634K Sell
1,692
-78
-4% -$30.3K 0.04% 255
2015
Q2
$694K Buy
1,770
+405
+30% +$145K 0.04% 258
2015
Q1
$472K Buy
+1,365
New +$455K 0.03% 276

Other funds holding ATRI

Rice Hall James & Associates's ATRI Position: Q2 2017 in Review

Rice Hall James & Associates sold out of Atrion Corp (ATRI) in Q2 2017, closing a stake of 1,917 shares — an estimated $898K sold.

Rice Hall James & Associates first reported a position in ATRI in Q1 2015 and held it in 9 quarters. The position peaked at $946K in Q4 2016. 117 funds tracked by Wall St. Rank hold ATRI as of Q2 2017.

  • Rice Hall James & Associates reported no remaining Atrion Corp position as of Q2 2017 after selling out during the quarter.
  • Rice Hall James & Associates sold 1,917 Atrion Corp shares in Q2 2017, an estimated $898K.
  • Rice Hall James & Associates first reported a position in Atrion Corp in Q1 2015 and held it in 9 quarters.
  • Rice Hall James & Associates's Atrion Corp position peaked at $946K in Q4 2016.
  • 117 funds tracked by Wall St. Rank held Atrion Corp as of Q2 2017.

Based on Rice Hall James & Associates's 13F filing for Q2 2017, filed 2 Aug 2017.